Hormone therapy risks are lower for women close to menopause

02/19/2010 | Medscape (free registration)

The benefit-risk profile for hormone therapy is better for women close to menopause but decreases over time as women age, according to a position statement by the North American Menopause Society. The updated guidelines include new sections on discontinuing HT and HT and ovarian and lung cancer.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Actuary
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC